Matches in SemOpenAlex for { <https://semopenalex.org/work/W3173024871> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W3173024871 endingPage "383" @default.
- W3173024871 startingPage "371" @default.
- W3173024871 abstract "Platinum-based drugs are the mainstay of chemotherapy regimens in a clinic, but their use is seriously limited by severe side effects and drug resistance. A cetuximab-decorated drug delivery system can selectively deliver drugs into EGFR-highexpressing cancer cells to prevent the shortcomings of platinum-based chemotherapy. Here, cetuximab-decorated and near-infrared (NIR)-activated nanoparticles based on Pt(IV)-prodrug (abbreviated as Cetuximab-Pt-INPs) was constructed. First, PEGylated Pt(IV)-prodrug was synthesized by a condensation reaction between c,c,t-[Pt(NH3)2Cl2(OOCCH2CH2COOH)(OH)] and MPEG-PLA. Then, Pt(IV)-prodrug and indocyanine green co-encapsulated nanoparticles (Pt-INPs) were prepared through an ultrasonic emulsification method. Finally, Cetuximab-Pt-INPs were obtained by decorating Pt-INPs with cetuximab as a targeting vector. The optimized Cetuximab-Pt-INPs exhibited a spherical core-shell shape of 138.5 ± 0.96 nm. In-vitro cellular uptake and cytotoxicity assays revealed that more Cetuximab-Pt-INPs with NIR irradiation were selectively taken up by A431 cells, thereby leading to higher cytotoxicity. These multifunctional nanoparticles may have promising potential for targeted and effective therapy against EGFR-highexpressing cells of epidermoid carcinoma." @default.
- W3173024871 created "2021-06-22" @default.
- W3173024871 creator A5002534200 @default.
- W3173024871 creator A5009592472 @default.
- W3173024871 creator A5019389336 @default.
- W3173024871 creator A5051765654 @default.
- W3173024871 creator A5081534428 @default.
- W3173024871 date "2021-01-01" @default.
- W3173024871 modified "2023-09-27" @default.
- W3173024871 title "Cetuximab-decorated and NIR-activated Nanoparticles Based on Platinum(IV)-prodrug: Preparation, Characterization and In-vitro Anticancer Activity in Epidermoid Carcinoma Cells." @default.
- W3173024871 doi "https://doi.org/10.22037/ijpr.2020.113439.14303" @default.
- W3173024871 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8170758" @default.
- W3173024871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34400966" @default.
- W3173024871 hasPublicationYear "2021" @default.
- W3173024871 type Work @default.
- W3173024871 sameAs 3173024871 @default.
- W3173024871 citedByCount "1" @default.
- W3173024871 countsByYear W31730248712021 @default.
- W3173024871 crossrefType "journal-article" @default.
- W3173024871 hasAuthorship W3173024871A5002534200 @default.
- W3173024871 hasAuthorship W3173024871A5009592472 @default.
- W3173024871 hasAuthorship W3173024871A5019389336 @default.
- W3173024871 hasAuthorship W3173024871A5051765654 @default.
- W3173024871 hasAuthorship W3173024871A5081534428 @default.
- W3173024871 hasConcept C108215921 @default.
- W3173024871 hasConcept C109316439 @default.
- W3173024871 hasConcept C121608353 @default.
- W3173024871 hasConcept C126322002 @default.
- W3173024871 hasConcept C178790620 @default.
- W3173024871 hasConcept C185592680 @default.
- W3173024871 hasConcept C192562407 @default.
- W3173024871 hasConcept C202751555 @default.
- W3173024871 hasConcept C2777516009 @default.
- W3173024871 hasConcept C2779998722 @default.
- W3173024871 hasConcept C2994460389 @default.
- W3173024871 hasConcept C502942594 @default.
- W3173024871 hasConcept C526805850 @default.
- W3173024871 hasConcept C55493867 @default.
- W3173024871 hasConcept C71924100 @default.
- W3173024871 hasConcept C98274493 @default.
- W3173024871 hasConceptScore W3173024871C108215921 @default.
- W3173024871 hasConceptScore W3173024871C109316439 @default.
- W3173024871 hasConceptScore W3173024871C121608353 @default.
- W3173024871 hasConceptScore W3173024871C126322002 @default.
- W3173024871 hasConceptScore W3173024871C178790620 @default.
- W3173024871 hasConceptScore W3173024871C185592680 @default.
- W3173024871 hasConceptScore W3173024871C192562407 @default.
- W3173024871 hasConceptScore W3173024871C202751555 @default.
- W3173024871 hasConceptScore W3173024871C2777516009 @default.
- W3173024871 hasConceptScore W3173024871C2779998722 @default.
- W3173024871 hasConceptScore W3173024871C2994460389 @default.
- W3173024871 hasConceptScore W3173024871C502942594 @default.
- W3173024871 hasConceptScore W3173024871C526805850 @default.
- W3173024871 hasConceptScore W3173024871C55493867 @default.
- W3173024871 hasConceptScore W3173024871C71924100 @default.
- W3173024871 hasConceptScore W3173024871C98274493 @default.
- W3173024871 hasIssue "1" @default.
- W3173024871 hasLocation W31730248711 @default.
- W3173024871 hasOpenAccess W3173024871 @default.
- W3173024871 hasPrimaryLocation W31730248711 @default.
- W3173024871 hasRelatedWork W1994880314 @default.
- W3173024871 hasRelatedWork W2046056968 @default.
- W3173024871 hasRelatedWork W2073502938 @default.
- W3173024871 hasRelatedWork W2083409726 @default.
- W3173024871 hasRelatedWork W2164924413 @default.
- W3173024871 hasRelatedWork W2167277715 @default.
- W3173024871 hasRelatedWork W2397903055 @default.
- W3173024871 hasRelatedWork W2462622469 @default.
- W3173024871 hasRelatedWork W2509171772 @default.
- W3173024871 hasRelatedWork W2762231152 @default.
- W3173024871 hasRelatedWork W2795541003 @default.
- W3173024871 hasRelatedWork W2888101988 @default.
- W3173024871 hasRelatedWork W2894282608 @default.
- W3173024871 hasRelatedWork W2901108996 @default.
- W3173024871 hasRelatedWork W2913231661 @default.
- W3173024871 hasRelatedWork W2993154169 @default.
- W3173024871 hasRelatedWork W2999008980 @default.
- W3173024871 hasRelatedWork W3048761769 @default.
- W3173024871 hasRelatedWork W3190730166 @default.
- W3173024871 hasRelatedWork W2926354727 @default.
- W3173024871 hasVolume "20" @default.
- W3173024871 isParatext "false" @default.
- W3173024871 isRetracted "false" @default.
- W3173024871 magId "3173024871" @default.
- W3173024871 workType "article" @default.